Comparative efficacy and tolerability of novel agents vs chemotherapy in relapsed and refractory T-cell lymphomas: a meta-analysis

Optimal treatment strategies for (relapsed and refractory [R/R]) peripheral T-cell lymphoma (PTCL) have not been well defined, and with the approval of several novel single agents (SA), the comparative efficacy of combination chemotherapy (CC) to single-agent strategies remains unclear. We conducted...

Descripción completa

Detalles Bibliográficos
Autores principales: Shafagati, Nazila, Koh, Min J., Boussi, Leora, Park, Hyun J., Stuver, Robert, Bain, Paul, Foss, Francine M., Shen, Changyu, Jain, Salvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631658/
https://www.ncbi.nlm.nih.gov/pubmed/35816645
http://dx.doi.org/10.1182/bloodadvances.2022007425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631658/
https://www.ncbi.nlm.nih.gov/pubmed/35816645
http://dx.doi.org/10.1182/bloodadvances.2022007425

Ejemplares similares